Healthcare -
Biotechnology - NASDAQ - US
$ 4.39
-1.84 %
$ 37.9 M
Market Cap
-0.36
P/E
KPTI - OTHER CURRENT LIABILITIES
Other Current Liabilities KPTI - Karyopharm Therapeutics Inc.
62.3 M
LAST VALUE
4.18%
2 YEAR CAGR
9.41%
5 YEAR CAGR
26.34%
10 YEAR CAGR